"Peanut Hypersensitivity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Allergic reaction to peanuts that is triggered by the immune system.
| Descriptor ID |
D021183
|
| MeSH Number(s) |
C20.543.480.370.572.750
|
| Concept/Terms |
Peanut Hypersensitivity- Peanut Hypersensitivity
- Groundnut Hypersensitivity
- Hypersensitivity, Groundnut
- Allergy, Peanut
- Allergies, Peanut
- Peanut Allergies
- Hypersensitivity, Peanut
- Peanut Allergy
|
Below are MeSH descriptors whose meaning is more general than "Peanut Hypersensitivity".
Below are MeSH descriptors whose meaning is more specific than "Peanut Hypersensitivity".
This graph shows the total number of publications written about "Peanut Hypersensitivity" by people in this website by year, and whether "Peanut Hypersensitivity" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 0 | 1 | 1 |
| 2017 | 2 | 0 | 2 |
| 2018 | 3 | 0 | 3 |
| 2019 | 1 | 0 | 1 |
| 2020 | 2 | 0 | 2 |
| 2021 | 1 | 0 | 1 |
| 2022 | 3 | 0 | 3 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Peanut Hypersensitivity" by people in Profiles.
-
Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy. N Engl J Med. 2023 05 11; 388(19):1755-1766.
-
Treatment of peanut allergy and colitis in mice via the intestinal release of butyrate from polymeric micelles. Nat Biomed Eng. 2023 Jan; 7(1):38-55.
-
Participant characteristics and safety outcomes of peanut oral immunotherapy in the RAMSES and ARC011 trials. Ann Allergy Asthma Immunol. 2022 12; 129(6):758-768.e4.
-
Interpreting success or failure of peanut oral immunotherapy. J Clin Invest. 2022 01 18; 132(2).
-
Immune changes beyond Th2 pathways during rapid multifood immunotherapy enabled with omalizumab. Allergy. 2021 09; 76(9):2809-2826.
-
Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study. J Allergy Clin Immunol Pract. 2021 05; 9(5):1879-1889.e13.
-
Origins of peanut allergy-causing antibodies. Science. 2020 03 06; 367(6482):1072-1073.
-
Food OIT: What do we know, what don't we know, and what do we need to know? Ann Allergy Asthma Immunol. 2019 08; 123(2):118-119.
-
Real-world attitudes among allergists/immunologists regarding oral immunotherapy and preferred terminology. J Allergy Clin Immunol Pract. 2019 02; 7(2):721-723.e9.
-
AR101 Oral Immunotherapy for Peanut Allergy. N Engl J Med. 2018 Nov 22; 379(21):1991-2001.